These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6262095)

  • 1. Buprenorphrine: demonstration of physical dependence liability.
    Dum J; Bläsig J; Herz A
    Eur J Pharmacol; 1981 Mar; 70(3):293-300. PubMed ID: 6262095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of morphine, naloxone, buprenorphine, butorphanol, haloperidol and imipramine on morphine withdrawal signs in cynomolgus monkeys.
    Fukase H; Fukuzaki K; Koja T; Nagata R; Lukas SE
    Psychopharmacology (Berl); 1994 Dec; 116(4):396-400. PubMed ID: 7701039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans.
    Schuh KJ; Walsh SL; Bigelow GE; Preston KL; Stitzer ML
    J Pharmacol Exp Ther; 1996 Aug; 278(2):836-46. PubMed ID: 8768738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed agonist-antagonist opiates and physical dependence.
    Jacob JJ; Michaud GM; Tremblay EC
    Br J Clin Pharmacol; 1979; 7 Suppl 3(Suppl 3):291S-296S. PubMed ID: 572694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical dependence induced by opiate partial agonists in the rat.
    McCarthy PS; Howlett GJ
    Neuropeptides; 1984 Dec; 5(1-3):11-4. PubMed ID: 6152317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intermittent naloxone attenuates the development of physical dependence on methadone in rhesus monkeys.
    Krystal JH; Walker MW; Heninger GR
    Eur J Pharmacol; 1989 Feb; 160(3):331-8. PubMed ID: 2540995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
    Rosado J; Walsh SL; Bigelow GE; Strain EC
    Drug Alcohol Depend; 2007 Oct; 90(2-3):261-9. PubMed ID: 17517480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine.
    Zamani N; Hassanian-Moghaddam H; Bayat AH; Haghparast A; Shadnia S; Rahimi M; Hashemi Demaneh B; Assar N
    Toxicol Lett; 2015 Feb; 232(3):590-4. PubMed ID: 25510513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of a single dose of morphine followed by naltrexone: substitution of other agonists for morphine and other antagonists for naltrexone in a rat model of acute dependence.
    Holtzman SG
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1033-41. PubMed ID: 12604679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphine-naloxone interactions: a role for nonspecific morphine excitatory effects in withdrawal.
    Stevens DR; Klemm WR
    Science; 1979 Sep; 205(4413):1379-8. PubMed ID: 224462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
    Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
    J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):628-38. PubMed ID: 7853176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans.
    Eissenberg T; Greenwald MK; Johnson RE; Liebson IA; Bigelow GE; Stitzer ML
    J Pharmacol Exp Ther; 1996 Feb; 276(2):449-59. PubMed ID: 8632309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence.
    Mori T; Komiya S; Uzawa N; Inoue K; Itoh T; Aoki S; Shibasaki M; Suzuki T
    Eur J Pharmacol; 2013 Sep; 715(1-3):238-45. PubMed ID: 23707904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
    Negus SS
    J Pharmacol Exp Ther; 2006 May; 317(2):711-23. PubMed ID: 16456085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist and antagonist properties of buprenorphine, a new antinociceptive agent.
    Cowan A; Lewis JW; Macfarlane IR
    Br J Pharmacol; 1977 Aug; 60(4):537-45. PubMed ID: 409448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation of morphine analgesia from physical dependence.
    Ling GS; MacLeod JM; Lee S; Lockhart SH; Pasternak GW
    Science; 1984 Oct; 226(4673):462-4. PubMed ID: 6541807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.